CN106722351A - 一种五毒麝香鼠及其麝香鼠肉 - Google Patents
一种五毒麝香鼠及其麝香鼠肉 Download PDFInfo
- Publication number
- CN106722351A CN106722351A CN201611105940.2A CN201611105940A CN106722351A CN 106722351 A CN106722351 A CN 106722351A CN 201611105940 A CN201611105940 A CN 201611105940A CN 106722351 A CN106722351 A CN 106722351A
- Authority
- CN
- China
- Prior art keywords
- scorpion
- centipede
- desman
- venom
- toad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000258920 Chilopoda Species 0.000 title claims abstract description 114
- 231100000614 poison Toxicity 0.000 title claims abstract description 103
- 241001071872 Desmana moschata Species 0.000 title claims abstract description 99
- 241000239226 Scorpiones Species 0.000 title claims abstract description 89
- 230000007096 poisonous effect Effects 0.000 title claims abstract description 82
- 241000270322 Lepidosauria Species 0.000 title claims abstract description 80
- 241000271897 Viperidae Species 0.000 title claims abstract description 80
- 235000013372 meat Nutrition 0.000 title claims abstract description 69
- 241000972155 Moschus Species 0.000 title abstract 4
- 239000007788 liquid Substances 0.000 claims abstract description 79
- 238000007670 refining Methods 0.000 claims abstract description 72
- 239000003998 snake venom Substances 0.000 claims abstract description 35
- 231100000611 venom Toxicity 0.000 claims abstract description 35
- 239000002435 venom Substances 0.000 claims abstract description 34
- 210000001048 venom Anatomy 0.000 claims abstract description 34
- 239000002795 scorpion venom Substances 0.000 claims abstract description 29
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 51
- 238000002347 injection Methods 0.000 claims description 33
- 239000007924 injection Substances 0.000 claims description 33
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 29
- 241000208340 Araliaceae Species 0.000 claims description 28
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 28
- 230000037396 body weight Effects 0.000 claims description 28
- 235000008434 ginseng Nutrition 0.000 claims description 28
- 210000003056 antler Anatomy 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000012467 final product Substances 0.000 claims description 13
- 235000013409 condiments Nutrition 0.000 claims description 12
- 230000001681 protective effect Effects 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 210000003462 vein Anatomy 0.000 claims description 10
- 239000008227 sterile water for injection Substances 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 6
- 210000001835 viscera Anatomy 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 42
- 230000036541 health Effects 0.000 abstract description 24
- 239000002574 poison Substances 0.000 abstract description 19
- 239000003814 drug Substances 0.000 abstract description 14
- 230000002457 bidirectional effect Effects 0.000 abstract description 13
- 230000001105 regulatory effect Effects 0.000 abstract description 13
- 239000003053 toxin Substances 0.000 abstract description 11
- 231100000765 toxin Toxicity 0.000 abstract description 11
- 230000002708 enhancing effect Effects 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 6
- 230000008859 change Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- 201000010099 disease Diseases 0.000 description 18
- 235000013305 food Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 10
- 235000014347 soups Nutrition 0.000 description 10
- 208000026106 cerebrovascular disease Diseases 0.000 description 8
- 230000002526 effect on cardiovascular system Effects 0.000 description 8
- 208000024172 Cardiovascular disease Diseases 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 235000019621 digestibility Nutrition 0.000 description 6
- 206010019468 Hemiplegia Diseases 0.000 description 5
- 241000270295 Serpentes Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000003088 amphibian venom Substances 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000005686 eating Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 208000004929 Facial Paralysis Diseases 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 241000271042 Gloydius halys Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241001416180 Moschidae Species 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003219 hemolytic agent Substances 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 241000402754 Erythranthe moschata Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000522620 Scorpio Species 0.000 description 2
- 206010044684 Trismus Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003556 anti-epileptic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- -1 per 2-3 days Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000009490 scorpio Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000269420 Bufonidae Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000086443 Craterellus fallax Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000027487 Fructose-Bisphosphatase Human genes 0.000 description 1
- 108010017464 Fructose-Bisphosphatase Proteins 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 102000005937 Tropomyosin Human genes 0.000 description 1
- 108010030743 Tropomyosin Proteins 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001738 cardenolides Chemical class 0.000 description 1
- 238000002554 cardiac rehabilitation Methods 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000003913 materials processing Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及保健产品技术领域,公开了一种五毒麝香鼠及其麝香鼠肉,利用蛇毒、蝎毒、蜈蚣毒、蟾蜍毒、壁虎精提液各种毒素的功效特性,以毒攻毒,经过百余次配方修改调整,科学配伍,与人们日常生活中常食的麝香鼠肉相结合,通过简单的日常食用五毒麝香鼠肉,实现人体机能的阴阳调和、双向调节、综合调理之功效,改善和增强人体体质及免疫力、防治疑难杂症,达到养生保健、延年益寿。既避免了安全风险,又方便了食用,将中华医学的精华与现代医学理论相结合,通过了毒理、功能检验报告,符合国家食品药品监督管理局关于保健食品的规定。
Description
技术领域
本发明涉及养生保健产品技术领域,特别涉及一种五毒麝香鼠及其麝香鼠肉。
背景技术
中医文化,博大精深,历史悠久,中医养生保健素来讲求药食同源,其食疗、药食同源及药膳理论与人类回归自然的愿望,提高生命健康素质的追求,自我保健、防患未然、扶正固本的目标相吻合,也与现代医学观点相一致,很多食材在中医上,都具有很好的药用价值。但是由于受地域限制,以及各族人民的饮食习惯不同,传统的药食同源食材很难大面积普遍推广食用,以成为人们日常养生调理的食物,通常这些食材仅在某一地区使用,而其他地区可能因风俗习惯、气候环境、交通信息、技术交流程度等原因影响,而不能广泛推广应用。另外,传统药食同源食材存在性能功效单一的缺陷,单一食用,往往不能实现对人体机能的全面阴阳调和、双向调节、综合调理之功效,通常需要多种食材相互搭配,共同食用,给食材加工、保存和日常食用带来极大不便。
近些年来,随着社会工业化的发展,人们的生存和生活环境受到严重污染,出现了越来越多的疑难杂症,诸如心脑血管疾病、癌症等,越来越多,呈逐年增长趋势。很多人都辛辛苦苦一辈子,积攒点积蓄,最后为治病救命而花的一无所有,治疗过程中还要遭受极大的痛苦,甚至债台高筑,还无法保全性命。
申请人经过多年潜心研究,以药食同源为基,通过中医以毒攻毒,结合运用高科技动植物提取工艺和生物转化技术,将中医文化中的五毒:蛇、蝎、蜈蚣、蟾蜍和壁虎中的不同毒素精提,经过百余次的配方修改调整,形成安全、科学、有效的有机配伍组合,五毒精华与日常食材有机结合,达到最佳的理想效果服务人类健康。上个世纪90年代,申请人先后开始进行蛇、蝎、蜈蚣的养殖,先后研制出了五毒液、五毒酒和五毒鸡,并于2002年12月18日就五毒鸡及其制备方法提出专利申请,经过十余年的潜心研究和发展,申请人不但对五毒液、五毒酒和五毒鸡进行了进一步的优化改良,而且使五毒的应用得以进一步广泛拓展。
发明内容
本发明所要解决的技术问题是将有机配伍、相辅相成的五毒精华与麝香鼠有机结合,提供一种五毒麝香鼠及其麝香鼠肉,通过以麝香鼠肉的形式作为日常食材,有效实现人们通过日常食用麝香鼠肉达到防治各种疑难杂症养生保健的目的,其配伍简单、安全、科学、有效,加工、保存、食用方便,通过简单的日常食用,即可实现对人体机能的全面阴阳调和、双向调节、综合调理之功效,有效增强人体体质和免疫能力,达到养生保健、防癌抗癌、防治心脑血管疾病等疑难杂症之功效。
为解决上述技术问题,本发明是通过如下的技术方案来实现:一种五毒麝香鼠,其特征在于,麝香鼠体内含有如下重量份配比的混合液:蛇毒6-8份、蝎毒4-7份、蜈蚣毒5-10份、蟾蜍毒0.8-1.2份、壁虎精提液12-16份。
优选的,所述混合液中还含有鹿茸精提液0.7-1.1份、人参精提液1.7-2.3份。
进一步优选地,所述混合液的配比为蛇毒7份、蝎毒6份、蜈蚣毒8份、蟾蜍毒1.1份、壁虎精提液14份、鹿茸精提液0.9份、人参精提液2份;或蛇毒7份、蝎毒5份、蜈蚣毒7.5份、蟾蜍毒1.2份、壁虎精提液15份、鹿茸精提液1份、人参精提液2.1份。
所述五毒麝香鼠采用如下方法获得:
1)将所述蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液,或蛇毒、蝎毒、蜈蚣毒、蟾蜍毒、壁虎精提液、鹿茸精提液和人参精提液,按所述重量份配比混合成混合液,并采用无菌注射用水将混合液的浓度稀释至1%;
2)将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液为1kg:1.5-2ml的比例注射不同剂量的混合液于麝香鼠的静脉血管内;
3)经7-10天的生物吸收转化后,即得。
所述步骤2)中,注射混合液时,按麝香鼠体重: 浓度为1%的混合液为1kg:0.3-0.4ml、1kg:0.5-0.6ml、1kg:0.7-1ml的比例,分次注射,每2-3天注射一次,效果更佳。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,真空包装,入库,于零下12-18℃温度下冷冻保存。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,洗净,加入适量调料,蒸煮至熟,放凉,真空包装,入库,于零下12-18℃温度下冷冻保存。
麝香鼠经济价值巨大,其分泌出的麝鼠香,具有浓烈的芳香味,既可以代替麝香作为名贵中药材,又是制作高级香水的原料,其毛皮底绒丰厚细软、皮板结实、坚韧、耐磨而轻柔、富有光泽,可制成高档裘皮大衣、皮帽等,沥水性强,不沾雨雪,其油脂可用于制皂、制革,以及作用燃料和油漆工业的附加剂等。其中麝鼠香还具有减慢心率、抗炎、耐缺氧、降血压、消炎、抗应敏等作用。本发明进一步拓展了五毒和麝香鼠的应用范围和经济价值。
本发明采用五毒:蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液,通过科学、合理配方,严格调控配方比例,使各毒素精华相互协调配合,并适应麝香鼠体之特性,各毒素精华以麝香鼠为载体,通过麝香鼠身体吸收转化,将五毒精华之功效,赋予麝香鼠体及其麝香鼠肉之中,通过食用麝香鼠肉,实现人体机能的阴阳调和、双向调节、综合调理之功效,改善和增强人体体质及免疫力、防治疑难杂症,实现养生保健,麝香鼠肉具有高蛋白、低脂肪之特点,营养极为丰富,五毒麝香鼠肉较未注射五毒混合液的普通麝香鼠肉,肉质更加细嫩、鲜美。进一步配以名贵中药鹿茸和人参精提液,名贵中药鹿茸和人参精提液起到画龙点睛的作用,显著增加阴阳调和、双向调节、综合调理之功效,使改善和增强人体体质及免疫力、养生保健、以及防治疑难杂症之功效得以显著提高。其中:
蛇毒【功效】祛风,通络,止痉。【主治】风湿顽痹,麻木拘挛,中风口眼歪斜,半身不遂,抽搐痉挛,破伤风症,麻风疥癣,瘰疬恶疮。“蛇性窜,能引药至风疾处,故能治风。风善行数变,蛇亦有善行数退,所以能透骨搜风,载惊定搐,为风痹惊搐、癞癣恶疮要药。取其内走脏腑,外彻皮肤,无处不到也”,即有穿骨祛风除湿治风湿的作用,能搜风定惊防治中风偏瘫,可通经络、通全身,使气血通畅,活血化淤,不生毒疖等,使机体各功能正常动作。蛇毒以选用长白山的白眉蝮蛇为上等,其毒素精提因子比其他蛇毒高出几十倍,有多达26种因子,如神经因子、溶血因子、凝血因子、控制癌细胞因子、抑制癌细胞因子等。
蝎毒【功效】祛风止经,通络、消肿、止痛,攻毒散结。【主治】风湿痹痛,中风,半身不遂,口眼歪斜,偏头痛,瘰疬,破伤风,风疹疮肿,无名肿痛,癌症,癫痫,顽固性皮肤病。蝎毒的功效是全蝎的18倍,以优选豫、陕、鄂三省交界地区八百里伏牛山产的十条腿中华钳蝎为上等,其喜食蜘蛛、蜈蚣,毒性猛烈,药用功效位于所有蝎子种系之首。
蜈蚣毒【功效】祛风,定惊,攻毒,散结。【主治】中风偏瘫,风湿,类风湿,惊痫,破伤风,抗肿瘤,百日咳,结核,疮疡肿毒,白秃,痔漏,烫伤。保护肝的排毒功能,保肝护胃,保护心脏。人体肝细胞在解毒的同时也受到损伤,蜈蚣毒使损伤的肝细胞得到修复,恢复肝脏旺盛的解毒功能。
蟾蜍毒【功效】破癥结,行水湿,化毒,杀虫拔毒,解毒,消肿,强心,止痛,定痛,抗癌防癌。【主治】疔疮,发背,阴疽瘰疬,恶疮,癓瘕癖积,臌胀,水肿,小儿疳积,慢性气管炎,消肿,强心止痛。
壁虎精提液【功效】祛风,定惊,散结,解毒。【主治】中风瘫痪,历节风痛,风痰惊痫,瘰疬,恶疮,骨髓炎,淋巴结核,肿瘤,对神经系统毛病、脑血管病能刺激脑细胞再生,防治偏瘫。壁虎精提液含蛋白质、马蜂毒样的有毒物质及组织胺样物质。
鹿茸【功效】壮元阳,补气血,益精髓,强筋骨。【主治】肾虚、头晕、耳聋、目暗、阳痿、滑精、宫冷不孕、羸瘦、神疲、畏寒、腰脊冷痛、筋骨痿软、崩漏带下、阴疽不敛及久病虚损等症。鹿茸有行血、化瘀、消肿、解毒和生肌的作用,对长期不愈和新生不良的溃疡及创伤,能增强其再生过程,加强氮素及碳水化合物的代谢,从而促进溃疡面和骨折的加速愈合。
人参【功效】大补元气,固脱生津,安神益智。【主治】劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之证。
虽然上述毒素通常情况下,直接作用于人体,会对人体产生毒害现象,但是申请人经过多年研制,通过安全合理配比和严格用量控制,以及采用麝香鼠机体的生物转化和吸收,实现对人体摄入量和药效成分的有效控制,在有效保障安全,避免对人体造成危害的情况下,使药效成分充分发挥作用,达到养生保健、防病、治病的目的。本发明中,蛇毒中具有神经因子、溶血因子、凝血因子、控制癌细胞因子、抑制癌细胞因子等26种活性因子,其生物转化成生物高蛋白,100%的被转化吸收,同时,富含多种氨基酸,如精氨酸、苯丙氨酸、酪氨酸、异亮氨酸、谷氨酸、苏氨酸、组氨酸等,是人体必需而自身不能合成或合成速度慢的“必需氨基酸”,还含有胆酸、果糖-1、6-二磷酸酶、原肌球蛋白等和多种矿物质元素,特别是长白山的白眉蝮蛇,其营养成分蛋白质含量,明显高于其他蛇类,并且远高于牛肉和羊肉。蝎毒系一种类似蛇毒神经毒的蛋白质,含有三甲胺、甜菜碱、牛磺酸、软脂酸、硬脂酸、胆甾醇、卵磷脂及铵盐等,其功效是全蝎的18倍。蝎毒中还含有:神经长肽,可修复损伤的神经,有效预防和治疗神经疾病,如半身不遂、三叉神经麻痹、口眼歪斜、神经衰弱等;溶血因子,防止血栓形成,溶解血栓,对因各种栓塞引起的中风、半身不遂具有任何其他药物所无法比拟的效果;心血管多肽,可有效软化血管、清除血管内壁的附着物,防治冠心病和高血压;抗癫痫多肽,具有抗癫痫效果;抗癌多肽,可有效杀灭癌细胞;解痉因子,具有很强的解痉作用;扩散因子,有效促进药物在机体内快速扩散和吸收。蝎毒对心脑血管病、神经系统疾病、风湿、类风湿、颈椎病、强直性脊椎炎、椎间盘突出等顽固性病痛疗效奇特。蟾蜍毒含强心甾烯蟾毒类、吲哚碱类、甾醇类等化学成分,还含有多糖、有机酸、氨基酸、肽类、肾上腺素等。鹿茸含有比人参更丰富的氨基酸、卵磷脂、维生素和微量元素等,可以提高机体的细胞免疫和体液免疫功能,促进淋巴细胞的转化,具有免疫促进剂的作用,增加机体对外界的防御能力,调节体内的免疫平衡而避免疾病发生和促进创伤愈合、病体康复,从而起到强壮身体、抵抗衰老的作用。人参对中枢神经系统具有兴奋作用,而大量时反而有抑制作用,能加强动物高级神经活动的兴奋和抑制过程,并能增强机体对一切非特异性刺激的适应能力,能减少疲劳感,对骨髓的造血功能有保护和刺激作用,能使正常和贫血动物红细胞数、白细胞数和血红蛋白量增加,对贫血病人也能使红细胞数、血红蛋白和血小板增加,当外周血细胞减少或骨髓受到抑制时,人参增加外周血细胞数的作用更加明显,人参通过增加骨髓DNA、RNA、蛋白质和脂质的合成,促进骨髓细胞有丝分裂,刺激造血功能。麝香鼠肉营养极为丰富,通过与本申请的混合液相结合,上述各药效成份相辅相成,首先共同作用于麝香鼠体,通过在麝香鼠体内注射所述重量份配比的混合液,麝香鼠体在吸收转化毒液的同时,使麝香鼠肉丰富的营养成分更利于人体吸收,提高有效吸收率。最终作用于人体,使各药效成份在人体内发挥作用,实现对人体机能的阴阳调和、双向调节、综合调理,改善和增强人体体质及免疫力,实现养生保健、防治疑难杂症的目的。
本发明将中华医学的精华与现代医学理论相结合,有机地将现代医学中的免疫学、营养学、内分泌学理论与祖国医学的五行学说、阴阳学说、脏腑学说等融为一体,以毒攻毒,利用各种毒素的功效特性,由18位国内一流动物毒素专家、生物制品专家、医药专家历经十余年,经过百余次配方修改调整,科学配伍,与人们日常生活中常食的麝香鼠肉相结合,协同配合,在药食同源的基础上,通过日常食用五毒麝香鼠肉,实现养生保健、防病、治病的目的,达到防癌抗癌,防治心脑血管疾病,有效改善和增强人体免疫能力和身体素质,防治各种疑难杂症,延年益寿的功效。
具体实施方式
下面通过具体实施方式,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明的五毒麝香鼠通过在麝香鼠体内注射由重量份为蛇毒6-8份、蝎毒4-7份、蜈蚣毒5-10份、蟾蜍毒0.8-1.2份、壁虎精提液12-16份配比的混合液而得,其中,蛇毒优选采用长白山的白眉蝮蛇蛇毒,壁虎精提液优选采用将壁虎冻死、开膛、去肠,于60℃温度下烘干,放入容器,加水熬液,滤渣取液获得。并且优选的,在所述混合液中混配有鹿茸精提液0.7-1.1份、人参精提液1.7-2.3份,鹿茸精提液和人参精提液可通过常规蒸馏法提取,并将提取液提纯、浓度浓缩至85%以上。通过将所述重量份配比的混合液采用无菌注射用水将浓度稀释至1%,根据麝香鼠体重的不同,按麝香鼠体重:浓度为1%的混合液为1kg: 1.5-2ml的比例注射于麝香鼠的静脉血管内,经过7-10天的生物吸收转化后,即可得到五毒麝香鼠。注射混合液时,优选按麝香鼠体重: 浓度为1%的混合液为1kg:0.3-0.4ml、1kg:0.5-0.6ml、1kg:0.7-1ml的比例,分次注射,每2-3天注射一次,可有效降低麝香鼠身体的应激不良反应,减少应激素的产生,提高有效药物成分的功效。
本发明的五毒麝香鼠肉通过将上述五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,真空袋包装,入库,于零下12-18℃温度下冷冻保存即得。或者采用将五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏后,直接洗净,加入适量调料,蒸煮至熟,放凉,真空包装,加工成开袋即可食用的熟食制品,入库,于零下12-18℃温度下冷冻保存。
实施例一
一种五毒麝香鼠,该五毒麝香鼠的体内注射有如下重量份配比的混合液:蛇毒8份,蝎毒7份,蜈蚣毒10份,蟾蜍毒0.8份,壁虎精提液16份,首先按该重量份配比将所述重量份的蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液混合成混合液,并采用无菌注射用水将混合液的浓度稀释至1%;然后将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液为1kg:1.5ml的比例注射混合液于麝香鼠的静脉血管内;注射混合液时,按麝香鼠体重: 浓度为1%的混合液为1kg:0.3ml、1kg:0.5ml、1kg:0.7ml的比例,分次注射,每2天注射一次,经7天的生物吸收转化后,即得。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,真空袋包装,入库,于零下12-18℃温度下冷冻保存即得。
食用时,将所得五毒麝香鼠肉解冻,加适量水及调料煮熟,吃肉喝汤。或者,解冻后,开袋,蒸熟,吃肉。
本实施例的五毒麝香鼠及麝香鼠肉,麝香鼠肉在人体内的消化吸收率可有效提高4-5倍,通过吃肉喝汤,对人体机能的阴阳调和、双向调节、综合调理之功效更佳,有效防癌抗癌,防治心脑血管疾病,增强人体体质和免疫能力,达到养生保健、防病治病、延年益寿的目的。
实施例二
一种五毒麝香鼠,该五毒麝香鼠的体内注射有如下重量份配比的混合液:蛇毒6份、蝎毒4份、蜈蚣毒5份、蟾蜍毒1份、壁虎精提液12份,首先按该重量份配比将所述重量份的蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液混合成混合液;并采用无菌注射用水将混合液的浓度稀释至1%;然后将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液为1kg:1.8ml的比例注射混合液于麝香鼠的静脉血管内;注射混合液时,按麝香鼠体重: 浓度为1%的混合液为1kg:0.4ml、1kg:0.6ml、1kg:0.8ml的比例,分次注射,每3天注射一次,经10天的生物吸收转化后,即得。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,真空袋包装,入库,于零下12-18℃温度下冷冻保存即得。
食用时,将所得五毒麝香鼠肉解冻,加适量水及调料煮熟,吃肉喝汤。或者,解冻后,开袋,蒸熟,吃肉。
本实施例的五毒麝香鼠及麝香鼠肉,麝香鼠肉在人体内的消化吸收率可有效提高4-6倍,通过吃肉喝汤,对人体机能的阴阳调和、双向调节、综合调理之功效更佳,有效防癌抗癌,防治心脑血管疾病,增强人体体质和免疫能力,达到养生保健、防病治病、延年益寿的目的。
实施例三
一种五毒麝香鼠,该五毒麝香鼠的体内注射有如下重量份配比的混合液:蛇毒6.5份、蝎毒5份、蜈蚣毒6份、蟾蜍毒0.9份、壁虎精提液13份、鹿茸精提液0.7份、人参精提液1.7份,首先按该重量份配比将所述重量份的蛇毒、蝎毒、蜈蚣毒、蟾蜍毒、壁虎精提液、鹿茸精提液和人参精提液混合成混合液,再用无菌注射用水将其浓度稀释至1%;然后将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液为1kg:1.7ml的比例注射混合液于麝香鼠的静脉血管内,注射混合液时,按麝香鼠体重: 浓度为1%的混合液为1kg:0.4ml、1kg:0.6ml、1kg:0.7ml的比例,分次注射,每2天注射一次,经8天的生物吸收转化后,即得。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,洗净,加入适量调料,蒸煮至熟,放凉,真空包装,入库,于零下12-18℃温度下冷冻保存。
食用时,开袋即食,或者开袋后加热食用均可,优选以加适量水及调料煮熟,吃肉喝汤。
本实施例的五毒麝香鼠及麝香鼠肉,麝香鼠肉在人体内的消化吸收率可有效提高6-8倍,通过采用鹿茸和人参精提液与蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液相调和,较实施例一和二单纯采用五毒毒液,可使对人体机能的阴阳调和、双向调节、综合调理之功效提高2-4倍,进一步有效提高增强人体体质和免疫能力、养生保健、防病治病、延年益寿的效果。
实施例四
一种五毒麝香鼠,该五毒麝香鼠的体内注射有如下重量份配比的混合液:蛇毒7.5份、蝎毒6份、蜈蚣毒8份、蟾蜍毒1.1份、壁虎精提液14份、鹿茸精提液1.1份、人参精提液2.3份,首先按该重量份配比将所述重量份的蛇毒、蝎毒、蜈蚣毒、蟾蜍毒、壁虎精提液、鹿茸精提液和人参精提液混合成混合液,再用无菌注射用水将浓度稀释至1%;然后将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液1kg:2ml的比例注射不同剂量的混合液于麝香鼠的静脉血管内,注射混合液时,按麝香鼠体重: 浓度为1%的混合液1kg:0.4ml、1kg:0.6ml、1kg:1ml的比例,分次注射,每3天注射一次,经9天的生物吸收转化后,即得。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,真空袋包装,入库,于零下12-18℃温度下冷冻保存即得。
食用时,将所得五毒麝香鼠肉解冻,加适量水及调料煮熟,吃肉喝汤。或者,解冻后,开袋,蒸熟,吃肉。
本实施例的五毒麝香鼠及麝香鼠肉,麝香鼠肉在人体内的消化吸收率可有效提高6-7倍,通过采用鹿茸和人参精提液与蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液相调和,较实施例一和二单纯采用五毒毒液,可使对人体机能的阴阳调和、双向调节、综合调理之功效提高3-5倍,进一步有效提高增强人体体质和免疫能力、养生保健、防病治病、延年益寿的效果。
实施例五
一种五毒麝香鼠,该五毒麝香鼠的体内注射有如下重量份配比的混合液:蛇毒7份、蝎毒6份、蜈蚣毒8份、蟾蜍毒1.1份、壁虎精提液14份、鹿茸精提液0.9份、人参精提液2份,首先按该重量份配比将所述重量份的蛇毒、蝎毒、蜈蚣毒、蟾蜍毒、壁虎精提液、鹿茸精提液和人参精提液混合成混合液,再用无菌注射用水将浓度稀释至1%;然后将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液1kg:1.9ml的比例注射不同剂量的混合液于麝香鼠的静脉血管内,注射混合液时,按麝香鼠体重: 浓度为1%的混合液1kg:0.4ml、1kg:0.6ml、1kg:0.9ml的比例,分次注射,每3天注射一次,经10天的生物吸收转化后,即得。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,洗净,加入适量调料,蒸煮至熟,放凉,真空包装,入库,于零下12-18℃温度下冷冻保存。
食用时,开袋即食,或者开袋后加热食用均可,优选以加适量水及调料煮熟,吃肉喝汤。
本实施例的五毒麝香鼠及麝香鼠肉,麝香鼠肉在人体内的消化吸收率可有效提高6-8倍,通过采用鹿茸和人参精提液与蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液相调和,较实施例一和二单纯采用五毒毒液,可使对人体机能的阴阳调和、双向调节、综合调理之功效提高4-5倍,进一步有效提高增强人体体质和免疫能力、养生保健、防病治病、延年益寿的效果。
实施例六
一种五毒麝香鼠,该五毒麝香鼠的体内注射有如下重量份配比的混合液:蛇毒7份、蝎毒5份、蜈蚣毒7.5份、蟾蜍毒1.2份、壁虎精提液15份、鹿茸精提液1份、人参精提液2.1份,首先按该重量份配比将所述重量份的蛇毒、蝎毒、蜈蚣毒、蟾蜍毒、壁虎精提液、鹿茸精提液和人参精提液混合成混合液,再用无菌注射用水将浓度稀释至1%;然后将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重: 浓度为1%的混合液为1kg:1.6ml的比例注射不同剂量的混合液于麝香鼠的静脉血管内;经7-10天的生物吸收转化后,即得。
一种五毒麝香鼠肉,通过将上述所得五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,洗净,加入适量调料,蒸煮至熟,放凉,真空包装,入库,于零下12-18℃温度下冷冻保存。
食用时,开袋即食,或者开袋后加热食用均可,优选以加适量水及调料煮熟,吃肉喝汤。
本实施例的五毒麝香鼠及麝香鼠肉,麝香鼠肉在人体内的消化吸收率可有效提高6-9倍,通过采用鹿茸和人参精提液与蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液相调和,较实施例一和二单纯采用五毒毒液,可使对人体机能的阴阳调和、双向调节、综合调理之功效提高4-6倍,进一步有效提高增强人体体质和免疫能力、养生保健、防病治病、延年益寿的效果。
实验例一
陈某,男,44岁,湖北英山县人,心脏病,心悸,疲劳无力,呼吸困难,食用本发明五毒麝香鼠肉,每天一只,一周后,疲劳感消失,呼吸困难和心悸症状减轻,三周后,体力明显增强,呼吸顺畅,两个月后,心悸症状消失,半年后,多年心脏病康复。后每周食用本发明五毒麝香鼠肉一只,至今无复发,且身体健康,面容优于常人,体力充沛。
实验例二
张某,女,46岁,江西宜春人,早期乳腺癌,2014年8月份经人介绍,开始食用本发明五毒麝香鼠肉,吃肉喝汤,每天食用一只,两周后,疼痛感减轻,一个月后,面色红润,疼痛感消失,肿块开始变小并逐渐消失,五个月后,全部肿块消失,后坚持每周食用一只本发明麝香鼠肉,吃肉喝汤,免疫力显著增强,至今无复发,且无感冒发生。
实验例三
曹某,男,58岁,湖南郴州人,高血压、高血脂、高血糖,浑身无力,食用本发明五毒麝香鼠肉,每天一只,二十天后,明显感觉体力恢复,两个月后,血压恢复正常,血脂、血糖明显降低,五个月后,三高症状消失,面色红润,气色佳,可上山砍柴,并独自背回家。
实验例四
李某,女,38岁,广东珠海,业务经理,身体素质如常人,于2015年8月开始食用本发明五毒麝香鼠肉,每周一只,十天后,面色红润,气色佳,三十天后,精力充沛,可连续出差一周,都不觉疲劳感,并且肌肤明显比之前光滑细腻,面容越来越好,半年后,自觉青春焕发,有年轻十岁之感。
上述实验例,仅为部分代表,以说明本发明通过科学、合理配方,使各毒素和药物精华与麝香鼠肉协同作用,以麝香鼠为载体,通过吸收转化,将各毒素和药物精华之功效,赋予麝香鼠及麝香鼠肉之中,同时改善和提高麝香鼠肉的性能与功效,使人们在日常生活饮食中,通过食用五毒麝香鼠肉,实现对身体机能的阴阳调和、双向调节、综合调理之功效,达到养生保健、防病、治病的目的,有效防癌抗癌,防治心脑血管疾病,有效增强体质和免疫能力,防治各种疑难杂症,延年益寿,食例众多,不再赘述。
本申请的五毒麝香鼠及其麝香鼠肉,通过了毒理、功能检验,符合国家食品药品监督管理局关于保健食品的规定。
本发明的技术方案并不限制于本发明所述的实施例的范围内。本发明未详尽描述的技术内容均为公知技术。
Claims (8)
1.一种五毒麝香鼠,其特征在于,麝香鼠体内含有如下重量份配比的混合液:蛇毒6-8份、蝎毒4-7份、蜈蚣毒5-10份、蟾蜍毒0.8-1.2份、壁虎精提液12-16份。
2.如权利要求1所述的五毒麝香鼠,其特征在于:所述混合液中还含有鹿茸精提液0.7-1.1份、人参精提液1.7-2.3份。
3.如权利要求2所述的五毒麝香鼠,其特征在于:所述混合液的配比为蛇毒7份、蝎毒6份、蜈蚣毒8份、蟾蜍毒1.1份、壁虎精提液14份、鹿茸精提液0.9份、人参精提液2份;或蛇毒7份、蝎毒5份、蜈蚣毒7.5份、蟾蜍毒1.2份、壁虎精提液15份、鹿茸精提液1份、人参精提液2.1份。
4.如权利要求1所述的五毒麝香鼠,其特征在于:采用如下方法获得:
1)将所述蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液,按所述重量份配比混合成混合液,并采用无菌注射用水将混合液的浓度稀释至1%;
2)将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重:混合液为1kg:1.5-2ml的比例注射不同剂量的混合液于麝香鼠的静脉血管内;
3)经7-10天的生物吸收转化后,即得。
5.如权利要求2所述的五毒麝香鼠,其特征在于:采用如下方法获得:
1)将所述蛇毒、蝎毒、蜈蚣毒、蟾蜍毒和壁虎精提液,按所述重量份配比混合成混合液,并采用无菌注射用水将混合液的浓度稀释至1%;
2)将浓度为1%的混合液抽入注射器内,根据麝香鼠体重的不同,按麝香鼠体重:混合液为1kg:1.5-2ml的比例注射不同剂量的混合液于麝香鼠的静脉血管内;
3)经7-10天的生物吸收转化后,即得。
6.如权利要求4或5所述的五毒麝香鼠,其特征在于:所述步骤2)中,注射混合液时,按麝香鼠体重:混合液为1kg:0.3-0.4ml、1kg:0.5-0.6ml、1kg:0.7-1ml的比例,分次注射,每2-3天注射一次。
7.一种五毒麝香鼠肉,其特征在于:将五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,真空包装,入库,于零下12-18℃温度下冷冻保存。
8.一种五毒麝香鼠肉,其特征在于:将五毒麝香鼠宰杀,剥皮,去头、尾、四肢及内脏,洗净,加入适量调料,蒸煮至熟,放凉,真空包装,入库,于零下12-18℃温度下冷冻保存。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611105940.2A CN106722351A (zh) | 2016-12-06 | 2016-12-06 | 一种五毒麝香鼠及其麝香鼠肉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611105940.2A CN106722351A (zh) | 2016-12-06 | 2016-12-06 | 一种五毒麝香鼠及其麝香鼠肉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106722351A true CN106722351A (zh) | 2017-05-31 |
Family
ID=58878942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611105940.2A Pending CN106722351A (zh) | 2016-12-06 | 2016-12-06 | 一种五毒麝香鼠及其麝香鼠肉 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106722351A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103519205A (zh) * | 2013-10-31 | 2014-01-22 | 蒋科富 | 一种竹鼠肉食品 |
CN104397754A (zh) * | 2014-12-23 | 2015-03-11 | 钟庆柱 | 一种保健竹鼠肉肠 |
-
2016
- 2016-12-06 CN CN201611105940.2A patent/CN106722351A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103519205A (zh) * | 2013-10-31 | 2014-01-22 | 蒋科富 | 一种竹鼠肉食品 |
CN104397754A (zh) * | 2014-12-23 | 2015-03-11 | 钟庆柱 | 一种保健竹鼠肉肠 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108498780B (zh) | 一种补肾壮阳组合物 | |
CN102934761B (zh) | 用于提高鱼类生产性能和免疫能力的饲料 | |
CN107739683A (zh) | 一种花菇小分子肽复配酒及其制备方法 | |
CN106578801A (zh) | 一种具有降糖作用的综合酵素粉及其制备方法 | |
CN107348365A (zh) | 一种新型纳豆多肽保健食品 | |
KR100840156B1 (ko) | 삼계탕 육수의 제조 방법 및 이를 이용한 삼계탕의 제조방법 | |
CN106722351A (zh) | 一种五毒麝香鼠及其麝香鼠肉 | |
CN106722286A (zh) | 一种五毒羊及其羊肉和羊肉汤 | |
CN106616435A (zh) | 一种五毒牦牛及其牦牛肉和牦牛肉汤 | |
CN106819876A (zh) | 一种五毒骆驼及其骆驼肉和骆驼肉汤 | |
CN106722285A (zh) | 一种五毒牛及其牛肉和牛肉汤 | |
CN106722287A (zh) | 一种五毒兔及其兔肉和兔肉汤 | |
CN106852298A (zh) | 一种五毒猪及其猪肉和猪肉汤 | |
CN106722284A (zh) | 一种五毒驴及其驴肉和驴肉汤 | |
CN106165894A (zh) | 一种冲调即食型多种食用菌复合营养粉及其生产方法 | |
CN106665483A (zh) | 一种五毒鹅及其鹅肉和鹅汤 | |
CN106722305A (zh) | 一种五毒鸭及其鸭肉和鸭汤 | |
CN106722306A (zh) | 一种五毒鸡及其鸡肉和鸡汤 | |
CN1220516C (zh) | 具有辅助抗癌作用的沙棘灵芝营养合剂 | |
CN105495584A (zh) | 一种增强机体免疫力的以花生蛋白为主的食品生产方法 | |
CN106727803A (zh) | 一种孕哺鸡及其肉和汤 | |
CN107460090B (zh) | 一种鹿龟保健酒及其制备方法 | |
CN103897957A (zh) | 富硒锗灵芝酵素酒 | |
CN105106744B (zh) | 一种治疗肾病综合症合并高脂血症的丸剂及制备方法 | |
CN106852282A (zh) | 一种五毒鱼及其鱼肉和鱼汤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |